Biotech10 months ago
Novartis Launches in Spain the First Therapy to Reduce Cholesterol
Novartis has acquired global rights to develop, manufacture, and commercialize Leqvio under a licensing and collaboration agreement with Alnylam Pharmaceuticals, which is a leader in RNA...